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SYSTEM DESIGN 
The architecture of the chip display
fluidic reservoir (P1) at the base of the ch
directly to the separation channel, a seconda
is at the top of the separation channel and 
port is directly below P2. Midway down
channel is the CD4 capture locus. On the 
the capture locus is a vent to allow any ov
during the cell separation process (Fig. 2). 
 
Figure 2: Finger-press actuated magne
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with the microfluidic features shown using
Schematic showing features of interest. D
when P1 is depressed or released is indicat
Green arrows respectively. 
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METHODOLOGY 
Chip manufacture 
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PDMS slab containing the microfluidic fea
on a 25 × 60 mm glass coverslip and allo
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Figure 5: Fluorescent analysis of images fr
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DISCUSSION AND CONCL
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